Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Safe Supply Streaming Portfolio Company Safety Strips, Provides Corporate Update (click to learn more) Saturn Oil & Gas Inc. Announces $525 Million Accretive Core-Area Saskatchewan Asset Acquisition (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News BioPharmX Corporation BPMX

Healthcare Biotechnology
"BioPharmX Corp specialty pharmaceutical company engaged in utilizing its proprietary drug delivery technologies to develop and commercialize novel prescription products that address large markets in dermatology. Its objective is to develop products that treat health or age-related conditions that are not presently being addressed or treated with drug therapies or drug delivery approaches that... see more

Recent & Breaking News (NYSEAM:BPMX)

BioPharmX Cancels Presentation at Oppenheimer's 28th Annual Healthcare Conference Due to Severe Weather

PR Newswire March 20, 2018

U.S. Patent and Trademark Office Awards BioPharmX Patent Protection for Novel Tetracycline-class Topical Drug Compositions

PR Newswire March 20, 2018

BioPharmX to Present at Oppenheimer's 28th Annual Healthcare Conference

PR Newswire March 14, 2018

BioPharmX to Present at 30th Annual ROTH Conference

PR Newswire March 5, 2018

BioPharmX To Present Data On New Fluorescence Lifetime Imaging Microscopy to Measure How Effectively Topically Applied Minocycline Reaches Targets in Skin

PR Newswire January 26, 2018

Biotech Stocks' Research Reports Released on Ampio Pharma, AmpliPhi Biosciences, Actinium Pharma, and BioPharmX

PR Newswire January 25, 2018

BioPharmX To Present BPX-04 Rosacea Data At Two Leading Clinical Conferences This Month

PR Newswire January 12, 2018

BioPharmX Reports Third Quarter 2018 Financial Results

PR Newswire December 7, 2017

BioPharmX Demonstrates Topical Minocycline Gel May Exhibit Relevant Antimicrobial and Anti-inflammatory Properties for the Treatment of Acne at ASCB 2017

PR Newswire December 4, 2017

BioPharmX Corporation Announces Pricing of Public Offering

PR Newswire November 21, 2017

BioPharmX Receives Concurrence from FDA on Phase 3 Acne Study Plans

PR Newswire November 8, 2017

Stock Performance Review on Biotech Industry -- Ampio Pharma, AmpliPhi Biosciences, Actinium Pharma, and BioPharmX

PR Newswire October 27, 2017

BioPharmX to Present at Re-entering Antibacterial Discovery and Development Summit 2017

PR Newswire October 18, 2017

BioPharmX Collaborates with Wellman Center for Photomedicine to Develop Pioneering, Cost-Effective Technique to Visualize Drug Delivery

PR Newswire October 11, 2017

BioPharmX Reports Second Quarter 2018 Financial Results

PR Newswire September 13, 2017

BioPharmX Announces Preliminary Data from Rosacea Feasibility Study

PR Newswire September 12, 2017

BioPharmX to Present at Rodman & Renshaw 19th Annual Global Investment Conference

PR Newswire September 5, 2017

Summer AAD Panel to Discuss BPX-01 for Acne and Rosacea

PR Newswire July 27, 2017

Stock Performance Review on Biotech Industry -- BioPharmX, AmpliPhi Biosciences, Actinium Pharma, and Matinas BioPharma

PR Newswire July 25, 2017

BioPharmX To Present Phase 2b Clinical Trial Data at National DEF Essential Resource Meeting 2017

PR Newswire July 13, 2017